Research Solutions, Inc. Files Q2 2025 10-Q

TL;DR

RSOL 10-Q filed for Dec 31, 2024. Standard financial update.

AI Summary

Research Solutions, Inc. filed its 10-Q for the period ending December 31, 2024. The company, formerly known as Derycz Scientific Inc, is incorporated in Nevada and operates in business services. Key financial statement dates and account types like common stock, retained earnings, and additional paid-in capital are referenced, indicating standard financial reporting for the quarter.

Why It Matters

This filing provides investors with an update on Research Solutions, Inc.'s financial performance and position as of December 31, 2024, crucial for understanding the company's ongoing operations and health.

Risk Assessment

Risk Level: low — This is a routine quarterly financial filing with no immediate red flags or significant new information presented in the provided snippet.

Key Numbers

• N/A — Revenue (Specific revenue figures for the quarter are not detailed in this snippet.)
• N/A — Net Income (Specific net income figures for the quarter are not detailed in this snippet.)
• N/A — Earnings Per Share (Specific EPS figures for the quarter are not detailed in this snippet.)

Key Players & Entities

• Research Solutions, Inc. (company) — Filer
• Derycz Scientific Inc (company) — Former company name
• 2024-12-31 (date) — Period of report
• 2025-02-14 (date) — Filing date

FAQ

Key Financial Figures

• $0.001 — nge on which registered Common stock, $0.001 par value RSSS The Nasdaq Stock Mar

Filing Documents

• rsss-20241231x10q.htm (10-Q) — 2580KB
• rsss-20241231xex10d1.htm (EX-10.1) — 223KB
• rsss-20241231xex31d1.htm (EX-31.1) — 13KB
• rsss-20241231xex31d2.htm (EX-31.2) — 13KB
• rsss-20241231xex32d1.htm (EX-32.1) — 6KB
• rsss-20241231xex32d2.htm (EX-32.2) — 6KB
• rsss-20241231x10q001.jpg (GRAPHIC) — 20KB
• rsss-20241231x10q002.jpg (GRAPHIC) — 24KB
• 0001558370-25-001010.txt ( ) — 9209KB
• rsss-20241231.xsd (EX-101.SCH) — 40KB
• rsss-20241231_cal.xml (EX-101.CAL) — 44KB
• rsss-20241231_def.xml (EX-101.DEF) — 233KB
• rsss-20241231_lab.xml (EX-101.LAB) — 357KB
• rsss-20241231_pre.xml (EX-101.PRE) — 318KB
• rsss-20241231x10q_htm.xml (XML) — 1821KB

— FINANCIAL INFORMATION

PART I — FINANCIAL INFORMATION 3

Condensed Consolidated Financial Statements (unaudited)

Item 1. Condensed Consolidated Financial Statements (unaudited) 3

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 24

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 37

Controls and Procedures

Item 4. Controls and Procedures 37

— OTHER INFORMATION

PART II — OTHER INFORMATION 38

Risk Factors

Item 1A. Risk Factors 38

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 38

Exhibits

Item 6. Exhibits 40

SIGNATURES

SIGNATURES 41 2 Table of Contents PART 1 — FINANCIAL INFORMATION

Condensed Consolidated Financial Statements

Item 1. Condensed Consolidated Financial Statements Research Solutions, Inc. and Subsidiaries Condensed Consolidated Balance Sheets December 31, 2024 June 30, (unaudited) 2024 Assets Current assets: Cash and cash equivalents $ 7,701,155 $ 6,100,031 Accounts receivable, net of allowance of $ 129,895 and $ 68,579 , respectively 7,116,055 6,879,800 Prepaid expenses and other current assets 742,166 643,553 Prepaid royalties 589,068 1,067,237 Total current assets 16,148,444 14,690,621 Non-current assets: Property and equipment, net of accumulated depreciation of $ 932,773 and $ 922,558 , respectively 63,355 88,011 Intangible assets, net of accumulated amortization of $ 2,129,868 and $ 1,535,310 , respectively 10,230,439 10,764,261 Goodwill 16,345,888 16,315,888 Deposits and other assets 867 981 Total assets $ 42,788,993 $ 41,859,762 Liabilities and Stockholders' Equity Current liabilities: Accounts payable and accrued expenses $ 8,104,118 $ 8,843,612 Deferred revenue 8,853,415 9,023,848 Contingent earnout liability, current portion 3,963,956 — Total current liabilities 20,921,489 17,867,460 Non-current liabilities: Contingent earnout liability, long-term portion 10,741,044 12,298,114 Total liabilities 31,662,533 30,165,574 Commitments and contingencies Stockholders' equity: Preferred stock; $ 0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding — — Common stock; $ 0.001 par value; 100,000,000 shares authorized; 32,640,407 and 32,295,373 shares issued and outstanding, respectively 32,640 32,295 Additional paid-in capital 38,836,646 38,089,958 Accumulated deficit ( 27,620,476 ) ( 26,309,246 ) Accumulated other comprehensive loss ( 122,350 ) ( 118,819 ) Total stockholders' equity 11,126,460 11,694,188 Total liabilities and stockholders' equity $ 42,788,993 $ 41,859,762 See notes to condensed consol

View Full Filing

View this 10-Q filing on SEC EDGAR